Which has preferable valuation & earnings, AUNA or NAKA?

Auna has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Auna $1.23B 0.30 $27.39M $0.26 18.98 KindlyMD $1.82M 41.30 -$52.23M -$43.20 N/A

Is AUNA or NAKA more profitable?

Auna has a net margin of 1.53% compared to KindlyMD's net margin of -7,397.12%. Auna's return on equity of 16.25% beat KindlyMD's return on equity. Company Net Margins Return on Equity Return on Assets Auna 1.53% 16.25% 4.03% KindlyMD -7,397.12% -81.32% -54.17%

Which has preferable earnings & valuation, NAKA or SBC?

SBC Medical Group has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 41.30 -$52.23M -$43.20 N/A SBC Medical Group $173.61M 1.70 $50.99M $0.39 7.36

Which has preferable valuation and earnings, LFMD or NAKA?

LifeMD has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LifeMD $194.05M 1.17 $14.35M $0.05 94.00 KindlyMD $1.82M 41.30 -$52.23M -$43.20 N/A

Is LFMD or NAKA more profitable?

LifeMD has a net margin of 2.37% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets LifeMD 2.37% -150.88% -22.59% KindlyMD -7,397.12% -81.32% -54.17%

Which has higher valuation & earnings, NAKA or BDSX?

Biodesix has higher revenue and earnings than KindlyMD. Biodesix is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 41.30 -$52.23M -$43.20 N/A Biodesix $88.50M 1.76 -$35.26M -$4.06 N/A

Is NAKA or BDSX more profitable?

Biodesix has a net margin of -33.26% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets KindlyMD -7,397.12% -81.32% -54.17% Biodesix -33.26% -2,101.40% -35.65%

Which has better valuation and earnings, XGN or NAKA?

Exagen has higher revenue and earnings than KindlyMD. Exagen is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Exagen $66.57M 1.69 -$19.95M -$0.89 N/A KindlyMD $1.82M 41.30 -$52.23M -$43.20 N/A

Is XGN or NAKA more profitable?

Exagen has a net margin of -29.49% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Exagen's return on equity. Company Net Margins Return on Equity Return on Assets Exagen -29.49% -94.37% -28.96% KindlyMD -7,397.12% -81.32% -54.17%

KindlyMD (NAKA) Competitors

$4.32 0.00 (0.00%)

As of 06/12/2026 04:00 PM Eastern

Compare

NAKA vs. AUNA, SBC, LFMD, BDSX, and XGN

Should you buy KindlyMD stock or one of its competitors? MarketBeat compares KindlyMD with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with KindlyMD include Auna (AUNA), SBC Medical Group (SBC), LifeMD (LFMD), Biodesix (BDSX), and Exagen (XGN). These companies are all part of the "healthcare" industry.

How does KindlyMD compare to Auna?

Auna (NYSE:AUNA) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

Auna has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, KindlyMD has a beta of 15.89, indicating that its share price is 1,489% more volatile than the broader market.

Auna has a net margin of 1.53% compared to KindlyMD's net margin of -7,397.12%. Auna's return on equity of 16.25% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Auna	1.53%	16.25%	4.03%
KindlyMD	-7,397.12%	-81.32%	-54.17%

Auna currently has a consensus target price of $6.97, suggesting a potential upside of 41.17%. KindlyMD has a consensus target price of $30.00, suggesting a potential upside of 594.44%. Given KindlyMD's higher probable upside, analysts plainly believe KindlyMD is more favorable than Auna.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Auna has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Auna	$1.23B	0.30	$27.39M	$0.26	18.98
KindlyMD	$1.82M	41.30	-$52.23M	-$43.20	N/A

In the previous week, KindlyMD had 2 more articles in the media than Auna. MarketBeat recorded 2 mentions for KindlyMD and 0 mentions for Auna. KindlyMD's average media sentiment score of 1.43 beat Auna's score of 0.00 indicating that KindlyMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Auna	Neutral
KindlyMD	Positive

Summary

Auna beats KindlyMD on 8 of the 14 factors compared between the two stocks.

How does KindlyMD compare to SBC Medical Group?

KindlyMD (NASDAQ:NAKA) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

SBC Medical Group has a net margin of 24.09% compared to KindlyMD's net margin of -7,397.12%. SBC Medical Group's return on equity of 15.90% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-7,397.12%	-81.32%	-54.17%
SBC Medical Group	24.09%	15.90%	11.61%

SBC Medical Group has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	41.30	-$52.23M	-$43.20	N/A
SBC Medical Group	$173.61M	1.70	$50.99M	$0.39	7.36

KindlyMD has a beta of 15.89, suggesting that its stock price is 1,489% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

KindlyMD presently has a consensus target price of $30.00, indicating a potential upside of 594.44%. SBC Medical Group has a consensus target price of $8.50, indicating a potential upside of 196.17%. Given KindlyMD's stronger consensus rating and higher probable upside, research analysts clearly believe KindlyMD is more favorable than SBC Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, KindlyMD and KindlyMD both had 2 articles in the media. KindlyMD's average media sentiment score of 1.43 beat SBC Medical Group's score of 1.28 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Positive
SBC Medical Group	Positive

60.8% of SBC Medical Group shares are owned by institutional investors. 24.5% of KindlyMD shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

SBC Medical Group beats KindlyMD on 9 of the 15 factors compared between the two stocks.

How does KindlyMD compare to LifeMD?

LifeMD (NASDAQ:LFMD) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

LifeMD presently has a consensus price target of $9.14, suggesting a potential upside of 94.53%. KindlyMD has a consensus price target of $30.00, suggesting a potential upside of 594.44%. Given KindlyMD's higher possible upside, analysts plainly believe KindlyMD is more favorable than LifeMD.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

LifeMD has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$194.05M	1.17	$14.35M	$0.05	94.00
KindlyMD	$1.82M	41.30	-$52.23M	-$43.20	N/A

35.5% of LifeMD shares are owned by institutional investors. 17.2% of LifeMD shares are owned by company insiders. Comparatively, 24.5% of KindlyMD shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

LifeMD has a net margin of 2.37% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	2.37%	-150.88%	-22.59%
KindlyMD	-7,397.12%	-81.32%	-54.17%

LifeMD has a beta of 1.98, indicating that its share price is 98% more volatile than the broader market. Comparatively, KindlyMD has a beta of 15.89, indicating that its share price is 1,489% more volatile than the broader market.

In the previous week, KindlyMD had 1 more articles in the media than LifeMD. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for LifeMD. LifeMD's average media sentiment score of 1.87 beat KindlyMD's score of 1.43 indicating that LifeMD is being referred to more favorably in the media.

Company	Overall Sentiment
LifeMD	Very Positive
KindlyMD	Positive

Summary

LifeMD beats KindlyMD on 10 of the 16 factors compared between the two stocks.

How does KindlyMD compare to Biodesix?

KindlyMD (NASDAQ:NAKA) and Biodesix (NASDAQ:BDSX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk.

Biodesix has a net margin of -33.26% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-7,397.12%	-81.32%	-54.17%
Biodesix	-33.26%	-2,101.40%	-35.65%

KindlyMD currently has a consensus price target of $30.00, indicating a potential upside of 594.44%. Biodesix has a consensus price target of $24.00, indicating a potential upside of 59.36%. Given KindlyMD's higher probable upside, analysts plainly believe KindlyMD is more favorable than Biodesix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Biodesix has higher revenue and earnings than KindlyMD. Biodesix is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	41.30	-$52.23M	-$43.20	N/A
Biodesix	$88.50M	1.76	-$35.26M	-$4.06	N/A

In the previous week, KindlyMD had 1 more articles in the media than Biodesix. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for Biodesix. Biodesix's average media sentiment score of 1.44 beat KindlyMD's score of 1.43 indicating that Biodesix is being referred to more favorably in the news media.

Company	Overall Sentiment
KindlyMD	Positive
Biodesix	Positive

21.0% of Biodesix shares are held by institutional investors. 24.5% of KindlyMD shares are held by company insiders. Comparatively, 23.2% of Biodesix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

KindlyMD has a beta of 15.89, meaning that its share price is 1,489% more volatile than the broader market. Comparatively, Biodesix has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market.

Summary

Biodesix beats KindlyMD on 8 of the 15 factors compared between the two stocks.

How does KindlyMD compare to Exagen?

Exagen (NASDAQ:XGN) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability.

75.3% of Exagen shares are held by institutional investors. 10.4% of Exagen shares are held by company insiders. Comparatively, 24.5% of KindlyMD shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Exagen has a net margin of -29.49% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Exagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exagen	-29.49%	-94.37%	-28.96%
KindlyMD	-7,397.12%	-81.32%	-54.17%

Exagen has higher revenue and earnings than KindlyMD. Exagen is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exagen	$66.57M	1.69	-$19.95M	-$0.89	N/A
KindlyMD	$1.82M	41.30	-$52.23M	-$43.20	N/A

In the previous week, Exagen had 2 more articles in the media than KindlyMD. MarketBeat recorded 4 mentions for Exagen and 2 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.43 beat Exagen's score of 0.61 indicating that KindlyMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Exagen	Positive
KindlyMD	Positive

Exagen has a beta of 2.01, suggesting that its stock price is 101% more volatile than the broader market. Comparatively, KindlyMD has a beta of 15.89, suggesting that its stock price is 1,489% more volatile than the broader market.

Exagen currently has a consensus target price of $9.25, indicating a potential upside of 98.07%. KindlyMD has a consensus target price of $30.00, indicating a potential upside of 594.44%. Given KindlyMD's higher possible upside, analysts plainly believe KindlyMD is more favorable than Exagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exagen	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Exagen beats KindlyMD on 9 of the 16 factors compared between the two stocks.

Get KindlyMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NAKA vs. The Competition

Export

Metric	KindlyMD	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$75.17M	$8.90B	$6.52B	$12.05B
Dividend Yield	N/A	1.71%	2.67%	5.66%
P/E Ratio	-0.10	24.23	24.00	24.42
Price / Sales	41.30	23.90	515.84	118.72
Price / Cash	N/A	13.73	27.48	37.92
Price / Book	0.09	5.53	10.60	6.82
Net Income	-$52.23M	$177.22M	$3.57B	$337.56M
7 Day Performance	-7.69%	1.54%	0.59%	1.16%
1 Month Performance	-42.40%	10.04%	1.54%	3.16%
1 Year Performance	-99.22%	5.88%	25.41%	30.60%

KindlyMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NAKA KindlyMD	4.6549 of 5 stars	$4.32 flat	$30.00 +594.4%	-99.2%	$75.17M	$1.82M	N/A	N/A	Positive News Gap Up
AUNA Auna	4.802 of 5 stars	$4.51 +0.2%	$6.97 +54.5%	-21.9%	$333.79M	$1.23B	17.35	15,254
SBC SBC Medical Group	3.7878 of 5 stars	$3.06 -4.4%	$8.50 +177.8%	-35.2%	$313.90M	$173.61M	7.85	N/A	Positive News Gap Up
LFMD LifeMD	3.4437 of 5 stars	$4.64 -1.2%	$9.14 +97.3%	-62.3%	$224.15M	$194.05M	92.72	230	Positive News Gap Up
BDSX Biodesix	3.6905 of 5 stars	$15.85 +2.6%	$22.00 +38.8%	+162.6%	$164.20M	$88.50M	N/A	220	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NAKA) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KindlyMD (NAKA) Competitors